Combined ruzasvir, uprifosbuvir shows suboptimal HCV pangenotypic efficacy

Press/Media: Press / Media

PeriodNov 8 2017

Media coverage

1

Media coverage

  • TitleCombined ruzasvir, uprifosbuvir shows suboptimal HCV pangenotypic efficacy
    Media name/outletHealio
    CountryUnited States
    Date11/8/17
    PersonsEric J Lawitz